View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
July 6, 2011

Bioniche to Acquire Assets of Plasvacc

Canada's Bioniche has entered into a letter of intent to purchase the business and assets of Australia-based Plasvacc Holdings. The acquisition includes the inventories, properties, plants, equipment and intellectual property of Plasvacc and its subsidiaries. The deal will

By cms admin

Canada’s Bioniche has entered into a letter of intent to purchase the business and assets of Australia-based Plasvacc Holdings.

The acquisition includes the inventories, properties, plants, equipment and intellectual property of Plasvacc and its subsidiaries.

The deal will meet Bioniche’s objective of selectively acquiring rights to commercially-important animal health products and technologies.

The transaction is conditional upon satisfactory completion of customary due diligence, receipt of regulatory approvals and the signing of definitive transaction documents.

The transaction is expected to close in August 2011.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology